Overview
- Editors:
-
-
Ricardo Azziz
-
Center for Androgen Related Disorders, Cedars-Sinai Medical Center; and Department of Obstetrics and Gynecology, and Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA
-
John E. Nestler
-
Department of Internal Medicine, Virginia Commonwealth University, Richmond
-
Didier Dewailly
-
Department of Endocrine Gynaecology and Reproductive Medicine, Lille University Hospital, Lille, France
Access this book
Other ways to access
Table of contents (39 chapters)
-
Front Matter
Pages i-xviii
-
-
Physiology of Androgens
-
-
- Walter L. Miller, David H. Geller, Mitchell Rosen
Pages 19-33
-
-
- T. Keta Hodgson, Glenn D. Braunstein
Pages 49-62
-
-
Uncommon Causes of Androgen Excess
-
Front Matter
Pages 75-144
-
- Michel Pugeat, Gérald Raverot, Ingrid Plotton, Aude Brac de la Perrière, Pascale Mirakian, Henri Déchaud et al.
Pages 75-84
-
- Anne-Céline Reyss, Didier Dewailly
Pages 85-89
-
- Didier Dewailly, Ricardo Azziz
Pages 91-106
-
-
- Barbara Neraud, Didier Dewailly
Pages 121-127
-
- David E. Moller, Antonio Vidal-Puig, Ricardo Azziz
Pages 129-138
-
-
The Polycystic Ovary Syndrome
-
Front Matter
Pages 145-362
-
-
- Walter Futterweit, Evanthia Diamanti-Kandarakis, Ricardo Azziz
Pages 155-167
-
About this book
The field of androgen excess disorders has advanced substantially since the original publication of this book. The Androgen Excess Society (AES) was founded to bring together investigators in the field. A better understanding of the screening, progression, and molecular genetics of nonclassic adrenal hyperplasia (NCAH) has improved the clinical care and diagnostic accuracy of these patients. New criteria for the diagnosis of the polycystic ovary syndrome (PCOS) were proposed in Rotterdam, criteria that have resulted in controversy and, hopefully, initiation of new studies. The association of insulin resistance with PCOS has been strengthened, and the role of metformin in tre- ing the infertility of the PCOS has been validated. Risks for diabetes and, more cont- versially, cardiovascular disease in women with PCOS have received substantial investigation. Our understanding of the epidemiology and economic impact of these disorders has expanded, emphasizing their critical importance. These are but a few highlights of how the terrain has changed in a relatively brief period of time. In keeping with these advances, the title of this book has been revised to reflect the growing importance of PCOS as the most prevalent androgen excess disorder in women, and arguably, as the one that might have the most serious adverse consequences for general health. There are fewer chapters to provide a more focused elucidation of the area. Several chapters were penned by new (and young) authors who are conducting cutting-edge research in the field.
Reviews
From the reviews:
"...a timely update of a rapidly mushrooming area of the reproductive literature." -TRENDS in Endocrinology andf Metabolism
"This is a thoughtful, focused approach to androgen excess in women. The book is well organized and the format makes identification of specific topics easy. … This book is targeted at both researchers and clinicians in the field of androgen excess and it serves that audience well. … a good resource. It is helpful to have so many aspects of androgen excess addressed in a single source by knowledgeable authors." (Suma Dronavalli, Doody’s Review Service, December, 2006)
Editors and Affiliations
-
Center for Androgen Related Disorders, Cedars-Sinai Medical Center; and Department of Obstetrics and Gynecology, and Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA
Ricardo Azziz
-
Department of Internal Medicine, Virginia Commonwealth University, Richmond
John E. Nestler
-
Department of Endocrine Gynaecology and Reproductive Medicine, Lille University Hospital, Lille, France
Didier Dewailly